<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="7" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font6" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font7" size="9" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font8" size="10" family="Symbol" color="#000000"/>
<text top="41" left="55" width="122" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Medical Immunology 2006, 5 :1<i>Medical Immunology</i></text>
<text top="41" left="384" width="170" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.medimmunol.com/content/5/1/1</text>
<text top="756" left="503" width="51" height="10" font="font1" id="p1_t3" reading_order_no="108" segment_no="13" tag_type="text">Page 5 of 14<b>5</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="109" segment_no="14" tag_type="text">(page number not for citation purposes)</text>
<text top="87" left="55" width="241" height="9" font="font4" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="text">or positive control EBV peptide at 640 molar excess in PBS</text>
<text top="98" left="55" width="241" height="9" font="font4" id="p1_t6" reading_order_no="3" segment_no="2" tag_type="text">pH 7.2 overnight. HIV-1B specific CD8 + cells were stained</text>
<text top="110" left="55" width="241" height="9" font="font4" id="p1_t7" reading_order_no="4" segment_no="2" tag_type="text">with peptide loaded A2:Ig fusion protein DimerX reagent<i>(page number not for citation purposes)</i></text>
<text top="122" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="5" segment_no="2" tag_type="text">and detected by PE-conjugated A85-1 mAb (anti-mouse</text>
<text top="134" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="6" segment_no="2" tag_type="text">IgG1, BD biosciences). DimerX staining was determined</text>
<text top="145" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="7" segment_no="2" tag_type="text">by flow cytometry (FACSAria, BD Biosciences). The nega-</text>
<text top="157" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="8" segment_no="2" tag_type="text">tive control straining was obtained using the HIV-1 spe-</text>
<text top="169" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="9" segment_no="2" tag_type="text">cific T cell line and a non-relevant HIV-1 peptide loaded</text>
<text top="181" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="10" segment_no="2" tag_type="text">DimerX. The positive control was obtained using donor</text>
<text top="192" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="11" segment_no="2" tag_type="text">PBMC's stimulated with 1uM BMLF-1 EBV peptide for one</text>
<text top="204" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="12" segment_no="2" tag_type="text">week and then stained with EBV peptide loaded Dimer X.</text>
<text top="228" left="55" width="241" height="9" font="font6" id="p1_t16" reading_order_no="13" segment_no="6" tag_type="title">Generation of HLA allele specific transfectants for peptide</text>
<text top="240" left="55" width="129" height="9" font="font6" id="p1_t17" reading_order_no="14" segment_no="6" tag_type="title">binding and restriction analysis</text>
<text top="251" left="55" width="98" height="9" font="font7" id="p1_t18" reading_order_no="15" segment_no="7" tag_type="title">Cell lines and RNA isolation</text>
<text top="263" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="16" segment_no="8" tag_type="text">HLA-homozygous human B-lymphoblastoid cell lines (B-</text>
<text top="275" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="17" segment_no="8" tag_type="text">LCL) from the International Histocompatibility Working</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="18" segment_no="8" tag_type="text">Group (IHWG) were thawed and grown in RPMI com-<i><b>Generation of HLA allele specific transfectants for peptide </b></i></text>
<text top="298" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="19" segment_no="8" tag_type="text">plete medium (RPMI supplemented with 10% FCS, 2 mM<i><b>binding and restriction analysis</b></i></text>
<text top="310" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="20" segment_no="8" tag_type="text">L-glutamine, 1 mM sodium pyruvate, and 1% pen-strep).<i>Cell lines and RNA isolation</i></text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="21" segment_no="8" tag_type="text">The HLA class I deficient 721.221 LCL line and the</text>
<text top="333" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="22" segment_no="8" tag_type="text">Amphopack 293, retroviral producer line, were main-</text>
<text top="345" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="23" segment_no="8" tag_type="text">tained in DMEM complete medium (DMEM supple-</text>
<text top="357" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="24" segment_no="8" tag_type="text">mented with 10% FCS, 2 mM L-glutamine, 1% pen-strep,</text>
<text top="369" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="25" segment_no="8" tag_type="text">1 mM sodium pyruvate). Total RNA was isolated from 5 ×</text>
<text top="380" left="55" width="241" height="9" font="font4" id="p1_t29" reading_order_no="26" segment_no="8" tag_type="text">10 6 B-LCL using the RNeasy kit (Qiagen) according to the</text>
<text top="392" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="27" segment_no="8" tag_type="text">manufacturer's instructions. The purified RNA was eluted</text>
<text top="402" left="55" width="241" height="13" font="font4" id="p1_t31" reading_order_no="28" segment_no="8" tag_type="text">in 50 ul RNase-free water and 10 μ l of this was used to</text>
<text top="416" left="55" width="241" height="9" font="font4" id="p1_t32" reading_order_no="29" segment_no="8" tag_type="text">synthesize cDNA using an oligo dT primer, dNTP mix,</text>
<text top="427" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="30" segment_no="8" tag_type="text">DTT, and M-MLV reverse transcriptase (200 u) (Gibco</text>
<text top="439" left="55" width="23" height="9" font="font4" id="p1_t34" reading_order_no="31" segment_no="8" tag_type="text">BRL).</text>
<text top="463" left="55" width="193" height="9" font="font7" id="p1_t35" reading_order_no="32" segment_no="9" tag_type="title">Primer, PCR amplification and cloning of PCR products</text>
<text top="474" left="55" width="241" height="9" font="font4" id="p1_t36" reading_order_no="33" segment_no="10" tag_type="text">HLA locus-specific primers were synthesized according to</text>
<text top="486" left="55" width="241" height="9" font="font4" id="p1_t37" reading_order_no="34" segment_no="10" tag_type="text">the information from [22]. Sense and antisense primers</text>
<text top="498" left="55" width="241" height="9" font="font4" id="p1_t38" reading_order_no="35" segment_no="10" tag_type="text">were made for each of HLA-A, HLA-B, and HLA-C with a</text>
<text top="510" left="55" width="241" height="9" font="font4" id="p1_t39" reading_order_no="36" segment_no="10" tag_type="text">HindIII site at the 5' end of sense and a NotI site at the 5'</text>
<text top="521" left="55" width="241" height="9" font="font4" id="p1_t40" reading_order_no="37" segment_no="10" tag_type="text">end of the antisense. PCR amplification was done using 2</text>
<text top="531" left="55" width="241" height="13" font="font8" id="p1_t41" reading_order_no="38" segment_no="10" tag_type="text">μ l of cDNA, 1× PCR buffer with Mg, 200 uM each dNTP,</text>
<text top="543" left="55" width="241" height="13" font="font4" id="p1_t42" reading_order_no="39" segment_no="10" tag_type="text">0.3 uM of each primer and 0.5 μ l Taq polymerase. The</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t43" reading_order_no="40" segment_no="10" tag_type="text">conditions for PCR were one cycle of 95°C for 5 min prior</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t44" reading_order_no="41" segment_no="10" tag_type="text">to addition of polymerase, followed by 30 cycles of 94°C<i>Primer, PCR amplification and cloning of PCR products</i></text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t45" reading_order_no="42" segment_no="10" tag_type="text">for 1 min, 58°C for 1 min, 68°C for 1.5 min and finally</text>
<text top="592" left="55" width="241" height="9" font="font4" id="p1_t46" reading_order_no="43" segment_no="10" tag_type="text">one cycle of 68°C for 4 min. PCR products were analyzed<a href="">22</a>]. Sense and antisense primers</text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t47" reading_order_no="44" segment_no="10" tag_type="text">on a 1.2 % agarose gel and gel purified using a gel extrac-</text>
<text top="613" left="55" width="241" height="13" font="font4" id="p1_t48" reading_order_no="45" segment_no="10" tag_type="text">tion kit (Qiagen # 28704). Subsequently, 6 μ l of purified</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t49" reading_order_no="46" segment_no="10" tag_type="text">PCR product was ligated into the pCR2.1 vector using the</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t50" reading_order_no="47" segment_no="10" tag_type="text">TA cloning kit (Invitogen, K2000-01) following the man-</text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t51" reading_order_no="48" segment_no="10" tag_type="text">ufacturer's directions. Transformation into INVaF' compe-</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t52" reading_order_no="49" segment_no="10" tag_type="text">tent cells was carried out and plated onto LB/ampicillin</text>
<text top="672" left="55" width="241" height="13" font="font4" id="p1_t53" reading_order_no="50" segment_no="10" tag_type="text">(100 μ g/ml) plates. After incubation at 37°C overnight,</text>
<text top="686" left="55" width="241" height="9" font="font4" id="p1_t54" reading_order_no="51" segment_no="10" tag_type="text">colonies were selected, grown and miniprep DNA pre-</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t55" reading_order_no="52" segment_no="10" tag_type="text">pared (QIAprep Spin Miniprep Kit (Qiagen 27104).</text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t56" reading_order_no="53" segment_no="10" tag_type="text">Clones were checked for inserts by restriction digestion</text>
<text top="721" left="55" width="241" height="9" font="font4" id="p1_t57" reading_order_no="54" segment_no="10" tag_type="text">with EcoR1. Several clones for each were sent for DNA</text>
<text top="87" left="313" width="241" height="9" font="font4" id="p1_t58" reading_order_no="55" segment_no="3" tag_type="text">sequencing using the vector primers M13 Reverse and T7</text>
<text top="98" left="313" width="241" height="9" font="font4" id="p1_t59" reading_order_no="56" segment_no="3" tag_type="text">promoter. Two additional primers designed to anneal in</text>
<text top="110" left="313" width="241" height="9" font="font4" id="p1_t60" reading_order_no="57" segment_no="3" tag_type="text">the middle of all HLA class I genes in the sense and anit-</text>
<text top="122" left="313" width="241" height="9" font="font4" id="p1_t61" reading_order_no="58" segment_no="3" tag_type="text">sense directions were also used [22]. All sequences were</text>
<text top="134" left="313" width="120" height="9" font="font4" id="p1_t62" reading_order_no="59" segment_no="3" tag_type="text">verified by DNA sequencing.</text>
<text top="157" left="313" width="219" height="9" font="font7" id="p1_t63" reading_order_no="60" segment_no="4" tag_type="title">Subcloning of HLA cDNAs into retroviral vector pLNCX2 and</text>
<text top="169" left="313" width="113" height="9" font="font7" id="p1_t64" reading_order_no="61" segment_no="4" tag_type="title">generation of viral supernatants</text>
<text top="181" left="313" width="241" height="9" font="font4" id="p1_t65" reading_order_no="62" segment_no="5" tag_type="text">Sequence-verified HLA cDNA clones were digested with</text>
<text top="192" left="313" width="241" height="9" font="font4" id="p1_t66" reading_order_no="63" segment_no="5" tag_type="text">HindIII and Not I and the insert was gel purified and sub-</text>
<text top="204" left="313" width="241" height="9" font="font4" id="p1_t67" reading_order_no="64" segment_no="5" tag_type="text">cloned into the retroviral vector, pLNCX2 (BD Bio-</text>
<text top="216" left="313" width="241" height="9" font="font4" id="p1_t68" reading_order_no="65" segment_no="5" tag_type="text">sciences, cat# 6102-1) which had been linearized with</text>
<text top="228" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="66" segment_no="5" tag_type="text">HindIII and NotI. Plasmid DNA preps were done and</text>
<text top="239" left="313" width="241" height="9" font="font4" id="p1_t70" reading_order_no="67" segment_no="5" tag_type="text">sequence was confirmed once again using the forward and</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t71" reading_order_no="68" segment_no="5" tag_type="text">reverse sequencing primers (BD Bioscience #K1060-F) for</text>
<text top="263" left="313" width="241" height="9" font="font4" id="p1_t72" reading_order_no="69" segment_no="5" tag_type="text">the vector, pLNCX2. Retroviral producer cell lines were</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t73" reading_order_no="70" segment_no="5" tag_type="text">established by transfection of the Amphopack 293 cell</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t74" reading_order_no="71" segment_no="5" tag_type="text">line using the HLA/pLNCX2 DNA. Amphopack 293 cells</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t75" reading_order_no="72" segment_no="5" tag_type="text">(4 × 10 6 ) were seeded onto a 100 mm tissue culture dish</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t76" reading_order_no="73" segment_no="5" tag_type="text">in 15 ml of DMEM complete medium and incubated over-</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t77" reading_order_no="74" segment_no="5" tag_type="text">night at 37°C. Five minutes prior to transfection, the<a href=""> [22]. A</a>ll sequences were</text>
<text top="333" left="313" width="241" height="9" font="font4" id="p1_t78" reading_order_no="75" segment_no="5" tag_type="text">medium was replaced with complete medium containing</text>
<text top="343" left="313" width="241" height="13" font="font4" id="p1_t79" reading_order_no="76" segment_no="5" tag_type="text">chloroquine (25 μ M). The semi-confluent cells were<i>Subcloning of HLA cDNAs into retroviral vector pLNCX2 and </i></text>
<text top="355" left="313" width="241" height="13" font="font4" id="p1_t80" reading_order_no="77" segment_no="5" tag_type="text">transfected using 20 μ g of plasmid DNA in combination<i>generation of viral supernatants</i></text>
<text top="366" left="313" width="241" height="13" font="font4" id="p1_t81" reading_order_no="78" segment_no="5" tag_type="text">with 61 μ l2 M CaCl 2 (0.5 ml total volume) and 0.5 ml 2</text>
<text top="380" left="313" width="241" height="9" font="font4" id="p1_t82" reading_order_no="79" segment_no="5" tag_type="text">× HBS, bubbled in. The solution was added dropwise to</text>
<text top="392" left="313" width="241" height="9" font="font4" id="p1_t83" reading_order_no="80" segment_no="5" tag_type="text">the cells and gently swirled. Plates were incubated at 37°C</text>
<text top="404" left="313" width="241" height="9" font="font4" id="p1_t84" reading_order_no="81" segment_no="5" tag_type="text">for 6–8 h, at which time the medium was removed and</text>
<text top="416" left="313" width="241" height="9" font="font4" id="p1_t85" reading_order_no="82" segment_no="5" tag_type="text">replaced with fresh DMEM complete medium. Plates were</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t86" reading_order_no="83" segment_no="5" tag_type="text">incubated further at 37°C for 48 h. At 48 h post-transfec-</text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t87" reading_order_no="84" segment_no="5" tag_type="text">tion the viral supernatant was removed from the plates</text>
<text top="451" left="313" width="241" height="9" font="font4" id="p1_t88" reading_order_no="85" segment_no="5" tag_type="text">and spun at 2000 rpm for 10 min, then filtered through a</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t89" reading_order_no="86" segment_no="5" tag_type="text">0.45 um filter. The supernatant was stored at 4°C for</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t90" reading_order_no="87" segment_no="5" tag_type="text">immediate infection or frozen at -80°C for later infection.</text>
<text top="498" left="313" width="241" height="9" font="font7" id="p1_t91" reading_order_no="88" segment_no="11" tag_type="title">Retroviral infection of 721.221 cells, flow cytometric analysis and cell</text>
<text top="510" left="313" width="24" height="9" font="font7" id="p1_t92" reading_order_no="89" segment_no="11" tag_type="title">sorting</text>
<text top="521" left="313" width="241" height="9" font="font4" id="p1_t93" reading_order_no="90" segment_no="12" tag_type="text">721.221 cells (EBV transfected B cell line which is MHC</text>
<text top="533" left="313" width="241" height="9" font="font4" id="p1_t94" reading_order_no="91" segment_no="12" tag_type="text">class 1 A, B, C negative) were infected with the retroviral</text>
<text top="545" left="313" width="241" height="9" font="font4" id="p1_t95" reading_order_no="92" segment_no="12" tag_type="text">supernatant using Lipofectamine reagent (Invitrogen</text>
<text top="556" left="313" width="241" height="10" font="font4" id="p1_t96" reading_order_no="93" segment_no="12" tag_type="text">#18324-111). For each infection, 1–3 × 10 6 cells in log</text>
<text top="566" left="313" width="241" height="13" font="font4" id="p1_t97" reading_order_no="94" segment_no="12" tag_type="text">phase were pelleted, resupended in 100 μ l of DMEM com-</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t98" reading_order_no="95" segment_no="12" tag_type="text">plete medium, and transferred to one well in a 24 well</text>
<text top="590" left="313" width="241" height="13" font="font4" id="p1_t99" reading_order_no="96" segment_no="12" tag_type="text">plate. 4 μ l of lipofectamine reagent, 2 ml of viral stock,</text>
<text top="604" left="313" width="241" height="9" font="font4" id="p1_t100" reading_order_no="97" segment_no="12" tag_type="text">and 0.2 ml of l M Hepes were added. The plate was spun</text>
<text top="615" left="313" width="241" height="9" font="font4" id="p1_t101" reading_order_no="98" segment_no="12" tag_type="text">for 1–2 h at 2000 rpm and subsequently the medium was</text>
<text top="627" left="313" width="241" height="9" font="font4" id="p1_t102" reading_order_no="99" segment_no="12" tag_type="text">discarded, the cells were washed one time with fresh</text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t103" reading_order_no="100" segment_no="12" tag_type="text">medium, and finally were resuspended in 2 ml of fresh</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t104" reading_order_no="101" segment_no="12" tag_type="text">medium. The following day, infected cells were put into</text>
<text top="660" left="313" width="241" height="13" font="font4" id="p1_t105" reading_order_no="102" segment_no="12" tag_type="text">neomycin (G418) selection at 800 μ g/ml. Selection was</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t106" reading_order_no="103" segment_no="12" tag_type="text">continued for 5–7 days at which point the concentration</text>
<text top="684" left="313" width="241" height="13" font="font4" id="p1_t107" reading_order_no="104" segment_no="12" tag_type="text">was dropped down to 400 μ g/ml. Approximately one</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t108" reading_order_no="105" segment_no="12" tag_type="text">week post-infection, the cells were analyzed for cell-sur-</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t109" reading_order_no="106" segment_no="12" tag_type="text">face expression of HLA. An aliquot of cells was stained</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t110" reading_order_no="107" segment_no="12" tag_type="text">using the monoclonal antibody W6/32 at 1:500, incu-</text>
</page>
</pdf2xml>
